Bo Liang
Administration
Adesso Advanced Materials
China
Biography
Under the direction of CEO and Co-Founder Bo Liang, PhD, MBA, Wuxi Adesso Nanotech was awarded a WuXi 530 Tech Pioneers Category A Grant to establish an R&D center and corporate headquarters in the WuXi Taihu Technology Park. Dr. Liang is a series entrepreneur and an experienced pharmaceutical scientist with extensive experience in drug development and biotechnology. He held over twenty five issued or pending US and international patents and has served as a reviewer for Bioorganic & Medicinal Chemistry. Before he retruned to China to found Wuxi Adesso Nanotech in 2009, he was Executive Vice President, Pharmaceutical Development, at Foresight Biotherapeutics, Inc. (New York). He is the Co-Founder of CLS Pharmaceuticals, Inc. (New York); Ecophalanx, Inc. (New Jersey) and Adeda Therapeutics (Hong Kong). Dr. Liang was a Senior Scientist at Pharmacopeia after receiving his PhD in chemistry from University of Pennsylvania. He also earned an MBA from the NYU Stern School of Business.
Research Interest
material Science
